Compare DNA & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DNA | ITIC |
|---|---|---|
| Founded | 2008 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.3M | 517.1M |
| IPO Year | N/A | N/A |
| Metric | DNA | ITIC |
|---|---|---|
| Price | $8.33 | $252.70 |
| Analyst Decision | Strong Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 19.2K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 6.23% |
| EPS Growth | N/A | ★ 25.81 |
| EPS | N/A | ★ 19.00 |
| Revenue | $180,606,000.00 | ★ $273,864,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.28 | N/A |
| P/E Ratio | ★ N/A | $13.38 |
| Revenue Growth | N/A | ★ 13.63 |
| 52 Week Low | $5.00 | $190.20 |
| 52 Week High | $17.58 | $288.98 |
| Indicator | DNA | ITIC |
|---|---|---|
| Relative Strength Index (RSI) | 35.56 | 44.08 |
| Support Level | $8.17 | $248.74 |
| Resistance Level | $8.90 | $260.66 |
| Average True Range (ATR) | 0.59 | 7.20 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 1.01 | 51.48 |
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.